Quarterly report pursuant to Section 13 or 15(d)

SEGMENT INFORMATION (Details)

v3.19.1
SEGMENT INFORMATION (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2019
USD ($)
segment
Mar. 31, 2018
USD ($)
Dec. 31, 2018
USD ($)
segment
Segment Reporting Information [Line Items]      
Number of operating segments | segment 2   2
Product sales, net $ 14,911 $ 8,071  
Gross profit 10,559 5,562  
Selling, general and administrative 18,595 4,740  
Research and development 1,342 154  
Operating income (loss) (9,378) 668  
Goodwill 2,788   $ 2,788
Intangible assets 3,792   3,801
Consumer Products Segment      
Segment Reporting Information [Line Items]      
Product sales, net 14,911 8,071  
Gross profit 10,559 5,562  
Selling, general and administrative 18,585 4,726  
Research and development 699 117  
Operating income (loss) (8,725) 719  
Specialty Pharmaceutical Segment      
Segment Reporting Information [Line Items]      
Product sales, net 0 0  
Gross profit 0 0  
Selling, general and administrative 10 14  
Research and development 643 37  
Operating income (loss) (653) $ (51)  
Goodwill 2,800   $ 2,800
Intangible assets $ 3,800